<DOC>
<DOCNO>
EP-0000121
</DOCNO>
<TEXT>
<DATE>
19790110
</DATE>
<IPC-CLASSIFICATIONS>
C07D-241/44 C07D-295/00 A61P-25/00 A61P-25/24 A61K-31/495 A61P-25/04 C07D-241/42 A61P-3/00 A61P-25/20 A61P-25/26 C07D-241/00 C07D-295/135 A61P-3/04 
</IPC-CLASSIFICATIONS>
<TITLE>
6-(1-piperazinyl)-quinoxaline, process for its preparation and pharmaceutical compositions thereof.
</TITLE>
<APPLICANT>
merck & co incus<sep>merck & co., inc. <sep>merck &amp; co., inc.126, east lincoln avenue p.o. box 2000rahway new jersey 07065-0900us   <sep>
</APPLICANT>
<INVENTOR>
lumma william carl jrus<sep>saari walfred spencerus<sep>lumma, william carl, jr.<sep>saari, walfred spencer<sep>lumma, william carl, jr.25 newman road, m.r. 1us-18073 pennsburg pennsylvaniaus<sep>saari, walfred spencer1740 wagon wheel laneus-19446 lansdale pennsylvaniaus<sep>
</INVENTOR>
<ABSTRACT>
6-(1-piperazinyl) quinoxaline and pharmaceutically  acceptable salts thereof have serotoninmimetic activity.  it is  prepared by reducing the nitro group of 1-(3-amino-4- nitrophenyl)  piperazine followed by treatment with glyoxal.  
</ABSTRACT>
</TEXT>
</DOC>
